How should we play our hand when holding an ACE?

[1] Law MR(2009)Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 b1665-1964

[2] Morris JK(2000)Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration Lancet 356 1955-S67

[3] Wald NJ(2004)Hypertension management in adults with diabetes Diabetes Care 27 S65-588

[4] Neal B(2006)Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials Lancet 368 581-871

[5] MacMahon S(2009)Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease Ann Intern Med 151 861-1847

[6] Chapman N(2008)Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 1839-1392

[7] Dagenais GR(1999)The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with agiotensin ll receptor antagonists Anesth Analg 89 1388-30

[8] Pogue J(2001)Should the angiotensin ll antagonists be discontinued before surgery? Anesth Analg 92 26-325

[9] Fox K(2008)Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period J Hosp Med 3 319-186

[10] Simoons ML(2008)Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker combined with diuretic therapy is associated with increased episodes of hypotensionin noncardiac surgery J Cardiothorac Vasc Anesth 22 180-321

[1] Law MR(2009)Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 b1665-1964

[2] Morris JK(2000)Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration Lancet 356 1955-S67

[3] Wald NJ(2004)Hypertension management in adults with diabetes Diabetes Care 27 S65-588

[4] Neal B(2006)Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials Lancet 368 581-871

[5] MacMahon S(2009)Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease Ann Intern Med 151 861-1847

[6] Chapman N(2008)Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 1839-1392

[7] Dagenais GR(1999)The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with agiotensin ll receptor antagonists Anesth Analg 89 1388-30

[8] Pogue J(2001)Should the angiotensin ll antagonists be discontinued before surgery? Anesth Analg 92 26-325

[9] Fox K(2008)Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period J Hosp Med 3 319-186

[10] Simoons ML(2008)Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker combined with diuretic therapy is associated with increased episodes of hypotensionin noncardiac surgery J Cardiothorac Vasc Anesth 22 180-321